1.Antimicrobial resistance and molecular epidemiologic characteristics of Stenotrophomonas maltophilia isolated from clinical specimens.
Sung Yong SEOL ; Kyoung Soo JANG ; Oung Gi JEONG ; Eung Rae CHO ; Neung Hee KIM ; Hak Sun YU ; Yoo Chul LEE ; Dong Taek CHO
Journal of the Korean Society for Microbiology 2000;35(3):239-250
Sixty-eight clinical isolates of Stenotrophomonas maltophilia from inpatients of 2 university hospitals in Taegu were epidemiologically analyzed by using the minimum inhibitory concentrations of 25 antimicrobial drugs, biochemical reaction, pulsed-field gel elctropgoresis (PFGE), and PCR with enterobacterial repetitive intergenic consensus sequences as primer (ERIC-PCR). 1. All the strains were susceptible to minocycline. More than 57% were susceptible to sulfisomidine (Su), ciprofloxacin (Ci), Ofloploxacin (Of), nalidixic acid (Na), and chloramphenicol (Cm), and 19apprx35% to ceftazidime (Cd), trimethoprim (Tp), Ticacillin-clavulanic acid, and cefoperazone-sulbactam. Most isolates were resistant to beta-lactam antibiotics such as ampicillin (Ap), carbenicillin (Cb), cefotaxim (Ct), cefoxitin (Cx), and aminoglycosides including gentamicin (Gm), tobramycin (Tb), amikacin (Ak). 2. All the isolates were multiply resistant of 5 to 17 drugs and showed 40 different resistance pattern types. 3. All the strains showed very similar biochemical reactions except beta-galactosidase and nitrate reduction test. Fourteen strains selected randomly were classified 10 different pattern type by PFGE and ERIC-PCR. These two methods showed identical result. Four strains isolated from wound in 1994 showed similar MIC pattern and identical API 20NE profile, PFGE, and ERIC-PCR pattern indicating episodes of cross-infection among patients. These results indicate that PFGE or ERIC-PCR profile has comparable discriminatory power for epidemiological typing of S. maltophilia.
Amikacin
;
Aminoglycosides
;
Ampicillin
;
Anti-Bacterial Agents
;
beta-Galactosidase
;
Carbenicillin
;
Cefotaxime
;
Cefoxitin
;
Ceftazidime
;
Chloramphenicol
;
Ciprofloxacin
;
Consensus Sequence
;
Daegu
;
Gentamicins
;
Hospitals, University
;
Humans
;
Inpatients
;
Microbial Sensitivity Tests
;
Minocycline
;
Nalidixic Acid
;
Polymerase Chain Reaction
;
Stenotrophomonas maltophilia*
;
Stenotrophomonas*
;
Sulfisomidine
;
Tobramycin
;
Trimethoprim
;
Wounds and Injuries